Elite Pharmaceuticals, Inc. (ELTP)
0.3931
-0.01
(-3.42%)
USD |
OTCM |
Feb 19, 16:00
Elite Pharmaceuticals EPS Diluted (Quarterly) : 0.0059 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 18.59M |
| Revenue (Quarterly) | 31.59M |
| Total Expenses (Quarterly) | 13.00M |
| Enterprise Value | 407.35M |
| Gross Profit Margin (Quarterly) | 39.78% |
| Profit Margin (Quarterly) | 58.86% |
| Earnings Yield | 5.52% |
| Operating Earnings Yield | 11.90% |
| Normalized Earnings Yield | 5.088 |